Adam Taylor Sullivan - 16 Jul 2026 Form 4 Insider Report for Core Scientific, Inc./tx (CORZ)

Reporting relationship
Chief Executive Officer, Director
Issuer ticker
CORZ
Reported as of
16 Jul 2026
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
20 Jul 2026, 16:16:35 UTC
Prior SEC filing
01 Jul 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Todd DuChene, as Attorney-in-Fact

Key filing fact

Adam Taylor Sullivan filed Form 4 for Core Scientific, Inc./tx (CORZ) on 20 Jul 2026.

Key facts

  • This page summarizes Adam Taylor Sullivan's Form 4 filing for Core Scientific, Inc./tx (CORZ).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 20 Jul 2026, 16:16.

Change

  • Previous filing in this sequence was filed on 01 Jul 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001980208 Primary reporting owner

Sullivan Adam Taylor

Relationship
Chief Executive Officer, Director
Address
C/O CORE SCIENTIFIC, INC., 838 WALKER ROAD, SUITE 21-2105, DOVER
Signature
/s/ Todd DuChene, as Attorney-in-Fact
Signature date
20 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CORZ transaction

Common Stock

Tax liability

Transaction value
Shares
-15,584
Change %
-0.35%
Price
$22.72*
Shares after
4,436,426
Date
16 Jul 2026
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .